01 8Pfizer Canada ULC
01 22517256
02 22577937
03 22578066
04 22632286
01 8Crizotinib
01 8Capsule
01 22024-02-26
02 42025-08-15
03 22026-11-23
Patent Expiration Date : 2024-02-26
Date Granted : 2013-04-30
Brand Name : XALKORI
Patent Number : 2517256
Filing Date : 2004-02-26
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-02-26
Date Granted : 2013-04-30
Patent Expiration Date : 2025-08-15
Date Granted : 2010-12-21
Brand Name : XALKORI
Patent Number : 2577937
Filing Date : 2005-08-15
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-08-15
Date Granted : 2010-12-21
Patent Expiration Date : 2026-11-23
Date Granted : 2011-11-15
Brand Name : XALKORI
Patent Number : 2632286
Filing Date : 2006-11-23
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-11-23
Date Granted : 2011-11-15
Patent Expiration Date : 2025-08-15
Date Granted : 2017-04-11
Brand Name : XALKORI
Patent Number : 2578066
Filing Date : 2005-08-15
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-08-15
Date Granted : 2017-04-11
Patent Expiration Date : 2024-02-26
Date Granted : 2013-04-30
Brand Name : XALKORI
Patent Number : 2517256
Filing Date : 2004-02-26
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-02-26
Date Granted : 2013-04-30
Patent Expiration Date : 2026-11-23
Date Granted : 2011-11-15
Brand Name : XALKORI
Patent Number : 2632286
Filing Date : 2006-11-23
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-11-23
Date Granted : 2011-11-15
Patent Expiration Date : 2025-08-15
Date Granted : 2017-04-11
Brand Name : XALKORI
Patent Number : 2578066
Filing Date : 2005-08-15
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-08-15
Date Granted : 2017-04-11
Patent Expiration Date : 2025-08-15
Date Granted : 2010-12-21
Brand Name : XALKORI
Patent Number : 2577937
Filing Date : 2005-08-15
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-08-15
Date Granted : 2010-12-21
